These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36328146)

  • 21. Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response.
    Bock JO; Ortea I
    Aging (Albany NY); 2020 Jun; 12(12):11277-11286. PubMed ID: 32575076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.
    Suresh V; Mohanty V; Avula K; Ghosh A; Singh B; Reddy RK; Parida D; Suryawanshi AR; Raghav SK; Chattopadhyay S; Prasad P; Swain RK; Dash R; Parida A; Syed GH; Senapati S
    FASEB J; 2021 Jul; 35(7):e21713. PubMed ID: 34105201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients.
    Mun DG; Vanderboom PM; Madugundu AK; Garapati K; Chavan S; Peterson JA; Saraswat M; Pandey A
    J Proteome Res; 2021 Aug; 20(8):4165-4175. PubMed ID: 34292740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic dyshomeostasis induced by SARS-CoV-2 structural proteins reveals immunological insights into viral olfactory interactions.
    Lachén-Montes M; Mendizuri N; Ausín K; Echaide M; Blanco E; Chocarro L; de Toro M; Escors D; Fernández-Irigoyen J; Kochan G; Santamaría E
    Front Immunol; 2022; 13():866564. PubMed ID: 36159830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
    Messina F; Giombini E; Montaldo C; Sharma AA; Zoccoli A; Sekaly RP; Locatelli F; Zumla A; Maeurer M; Capobianchi MR; Lauria FN; Ippolito G
    Cell Death Dis; 2021 Aug; 12(8):788. PubMed ID: 34385425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2.
    Xu G; Wu Y; Xiao T; Qi F; Fan L; Zhang S; Zhou J; He Y; Gao X; Zeng H; Li Y; Zhang Z
    Signal Transduct Target Ther; 2022 Sep; 7(1):312. PubMed ID: 36071039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity Assessment.
    Nuñez E; Orera I; Carmona-Rodríguez L; Paño JR; Vázquez J; Corrales FJ
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in understanding COVID-19: insights from the omics approach.
    Lin B; Liu J; Liu Y; Qin X
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):242-252. PubMed ID: 33375876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.
    Geyer PE; Arend FM; Doll S; Louiset ML; Virreira Winter S; Müller-Reif JB; Torun FM; Weigand M; Eichhorn P; Bruegel M; Strauss MT; Holdt LM; Mann M; Teupser D
    EMBO Mol Med; 2021 Aug; 13(8):e14167. PubMed ID: 34232570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.
    Aggarwal S; Acharjee A; Mukherjee A; Baker MS; Srivastava S
    J Proteome Res; 2021 Feb; 20(2):1107-1132. PubMed ID: 33426872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlates with Vaccine Protective Capacity and COVID-19 Disease Symptoms Identified by Serum Proteomics in Vaccinated Individuals.
    Villar M; Urra JM; Artigas-Jerónimo S; Mazuecos L; Contreras M; Vaz-Rodrigues R; Rodríguez-Del-Río FJ; Gortázar C; de la Fuente J
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection.
    Bauer W; Weber M; Diehl-Wiesenecker E; Galtung N; Prpic M; Somasundaram R; Tauber R; Schwenk JM; Micke P; Kappert K
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation.
    Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL
    J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients.
    Akgun E; Tuzuner MB; Sahin B; Kilercik M; Kulah C; Cakiroglu HN; Serteser M; Unsal I; Baykal AT
    PLoS One; 2020; 15(10):e0240012. PubMed ID: 33079950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
    Rohilla S
    Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods.
    Yu S; Li X; Xin Z; Sun L; Shi J
    Front Immunol; 2022; 13():923387. PubMed ID: 36203586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system.
    Ayass MA; Cao W; Zhang J; Dai J; Zhu K; Tripathi T; Griko N; Pashkov V; Abi-Mosleh L
    PLoS One; 2022; 17(9):e0274228. PubMed ID: 36094909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond.
    Zhu Y; Chen X; Liu X
    Front Immunol; 2022; 13():838011. PubMed ID: 35309344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.